Technical Analysis on MARKSANS MARKSANS looking good for short term.
Entry above 62.5
SL: 61
Target: 67
R:R 1:4
MARKSANS trade ideas
MARKSANS PHARMA Long MARKSANS PHARMA great stock to buy now at discounted price
FUNDAMENTAL
2x of book value👍
dividend yield half percent👍
look at ROCE almost 40% and ROE 32% fantastic for a company 💪💪💪
recently the company has reduced its debt its has only little debt
💪💪
important factor to watch out is the pe ration which is very less in indutry average almost all the companies have more PE 🔥🔥🔥🔥💪💪💪
companys sales volume is constantly rising👍👍👍
everything excellent🚀🔥
only thing is FIIi reduced thier stake in recent quarter i dont know why they may buy again possible ⚠️ 😂
Marksans Pharma: Expected RallyThis is my view on MARKSANS;
CMP 69.85 | T1: 98 (~40%) | T2: 108 (~55%)
The rationale for the going long:
- Stock moves up with high volumes and pullback occur with lower volumes.
- Base formation (consolidation) at 66-69 Levels
- RSI Bullish Divergence.
- Highest revenue and net profits in FY 2021 & TTM QE June 2021 (in past 10years).
- Low PE of ~11 compared to the ~24 of industry.
Readers, please note this is meant for educational purposes only.
MARKSONS - MAKE A MARKDISCLOSURE
This is only for educational purpose
This is not a recommendation
I am not SEBI registered
Do not TRADE/INVEST basis what I publish here
I am not responsible for your loss or gain
It is prudent to assume that I have ulterior motives in publishing this Idea
I and my clients might or might not have a position, I and my clients might or might not have a opposite position
VIEW :- POSITIVE FOR SHORT TERM
Long in Marksans Pharma,Buy CMP 72
Target 76,78 81
SL 69.
This is only for educational purpose
This is not a recommendation
Marksans Pharma Support Long TermMarksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. Its product portfolio spreads over major therapeutic areas such as oncology, gastroenterology, anti-diabetic, cardiovascular, pain management, and gynecology. The company was founded by Mark Bosco Saldanha on April 16, 1992 and is headquartered in Mumbai, India.
Buy at 70. Buy more at 50, 35
Target 100 for Short Term, 500 for Long Term
Duration 5 Years
Fundamental Snippets:
Market Cap - ₹ 2,837 Cr.
Current Price - ₹ 69.6
High / Low - ₹ 97.6 / 45.0
Stock P/E - 11.3
Book Value - ₹ 21.7
Dividend Yield - 0.36 %
ROCE - 38.9 %
ROE - 31.2 %
Face Value - ₹ 1.00
Debt to equity - 0.04
Price to book value - 3.20
PEG Ratio - 0.46
Promoter holding - 48.2 %
Change in Prom Hold - 0.00 %
Working capital - ₹ 629 Cr.
WC Days - 110
EVEBITDA - 7.40
Inven TO - 1.89
Current ratio - 3.30
Quick ratio - 1.82
Enterprise Value - ₹ 2,658 Cr.
EPS - ₹ 6.15
EPS preceding year - ₹ 2.95
Bullish on Marksans PharmaMarksans pharma has taken a good support from 200ema and last three green candles send out a real bullish signal. Expecting a bullish divergence.
MARKSANS - Price and Trend SetupStock is showing signs of reversal with volume spike at bottom of downtrend.
Multibagger story ?Stock may find support in 64-56 zone . Expect to be a 3 times + story from this zone. 49 on DCB is stop loss.
Disc : it's not an investment advice to buy or sell
buy above given level strictly....do your own study alsoDear friends ,please study yourself its a good stock to invest in near term
Sure Breakout is Ahead ✌✌✌This scrip has formed Descending Triangle and expcted to Give breakout. So traders keep on your radar to catch the momentum and enjoy the profit. Kindly like and share it to all your friends and needy people. Thanks to all.
Markan Pharma 1DIt is in consolidation for the past one month and ready for the next move. Do add it to your watchlist and wait for breakout.
MARKSANS: Nearing BreakoutNSE:MARKSANS
Levels mentioned in Chart.
Note: Not a SEBI Registered analyst.
Trade at your own discretion.
MARKSANS PHARMA--> Quick 12% upside potential The above references an opinion and is for information purposes only. It is not intended to be investment advice. Seek a duly licensed professional for investment advice.
